Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Effect of Lycopene on Serum Level of Cardiac Biomarkers in Patients Undergoing Elective Percutaneous Coronary Intervention: A Randomized Controlled Clinical Trial Publisher



Asgary S1 ; Soltani R2 ; Daraei F3 ; Salehizadeh L4 ; Vaseghi G5 ; Sarrafzadegan N6
Authors
Show Affiliations
Authors Affiliations
  1. 1. Cardiac Rehabilitation Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Department of Clinical Pharmacy and Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Students Research Committee, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran
  4. 4. Heart Failure Research Center, Cardiovascular Research Institute, Isfahan University of Medical Science, Isfahan, Iran
  5. 5. Applied Physiology Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
  6. 6. Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran

Source: ARYA Atherosclerosis Published:2021


Abstract

BACKGROUND: Myocardial ischemia may recur in a significant subset of patients following percutaneous coronary intervention (PCI). Lycopene, a carotenoid with antioxidant activity, has evidence for beneficial effects on cardiovascular system. In the present study, we aimed to evaluate the possible preventive effect of lycopene against post-PCI myocardial damage by detection of cardiac biomarkers of ischemia. METHODS: A total of 45 patients who planned to undergo elective PCI were randomly assigned to two groups to receive either lycopene (30 mg 12 hours before PCI as well as 15 mg just before and 8 hours after PCI) along with standard treatment (n = 23) or only standard treatment (n = 22). Standard treatment included aspirin, a statin, and a beta-blocker. The serum levels of creatine kinase-MB (CK-MB), troponin I, and high sensitivity C-reactive protein (hs-CRP) were measured 12 hours before and 12 hours after the procedure and were compared between the two groups. RESULTS: The use of lycopene significantly prevented the increase of CK-MB following PCI compared to control (P = 0.048). However, it had not any significant effect on serum levels of troponin I (TnI) (P = 0.176) and hs-CRP (P = 0.186) compared to control. CONCLUSION: Lycopene can prevent the increase of CK-MB following PCI. Therefore, it has the potential for prevention of post-PCI cardiovascular events. However, more studies are needed to confirm such an effect. © 2021, Isfahan University of Medical Sciences(IUMS). All rights reserved.
Related Docs
View other Related Docs
1. Risk Reduction and Prevention of Cardiovascular Diseases: Biological Mechanisms of Lycopene, Bioactive Compounds in Health and Disease (2022)
2. Prediction of Short-Term Clinical Outcome of Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome Through Myeloperoxidase Levels, ARYA Atherosclerosis (2014)
3. Enhanced Plasma Level of Lipid Peroxidation in Iranians Could Be Improved by Antioxidants Supplementation, European Journal of Clinical Nutrition (1997)
4. Pentoxifylline and Prevention of Contrast-Induced Nephropathy: Is It Efficient in Patients With Myocardial Infarction Undergoing Coronary Angioplasty?, ARYA Atherosclerosis (2016)
5. The Effects of Cranberry on Cardiovascular Metabolic Risk Factors: A Systematic Review and Meta-Analysis, Clinical Nutrition (2020)
6. Aspirin Resistance Status As Determined by Urinary Thromboxane B 2 (Txb2) Level in Patients With Ischemic Heart Disease and Its Relationship With Severity of Coronary Artery Disease, Journal of Isfahan Medical School (2011)
7. Association Between the Platelet-To-Lymphocyte Ratio and the No-Reflow Phenomenon and Thrombolysis in Myocardial Infarction Flow 3 After Primary Percutaneous Coronary Intervention in Patients With St-Segment Elevation Myocardial Infarction, Iranian Heart Journal (2017)
8. Impact of Allopurinol Pretreatment on Coronary Blood Flow and Revascularization Outcomes After Percutaneous Coronary Intervention in Acute Stemi Patients: A Randomized Double Blind Clinical Trial, ARYA Atherosclerosis (2023)
Experts (# of related papers)
View all Related Experts
Masoumeh Sadeghi (10)
Afshin Amirpour (4)
Other Related Docs
9. The Effect of N-Acetylcysteine in Prime Solution on Reducing Damage to the Myocardium in Open Heart Surgery, Journal of Isfahan Medical School (2024)
10. Possible Effects of Melatonin on Reperfusion Injury Following Coronary Artery Bypass Graft Surgery, ARYA Atherosclerosis (2022)
11. The Correlation Between Early Complications of Percutaneous Coronary Intervention and High Sensitive C-Reactive Protein, ARYA Atherosclerosis (2013)
12. The Protective Effect of Lycopene Supplement Against Vancomycin-Induced Nephrotoxicity; a Randomized Double-Blind Placebo-Controlled Clinical Trial, Journal of Renal Injury Prevention (2020)
13. The Assessment of No-Reflow Phenomenon Incidence in Early Versus Delayed Percutaneous Coronary Intervention Following a Primary Fibrinolysis, ARYA Atherosclerosis (2024)
14. Effect of Cardiac Rehabilitation on Inflammation: A Systematic Review and Meta-Analysis of Controlled Clinical Trials, ARYA Atherosclerosis (2018)
15. Functional Food and Cardiovascular Disease Prevention and Treatment: A Review, Journal of the American College of Nutrition (2018)
16. Irisin, a New Biomarker in Diagnosis of Atherosclerosis and Myocardial Infarction, Journal of Isfahan Medical School (2015)
17. Resistin and Prooxidant-Antioxidant Balance: Markers to Discriminate Acute Coronary Syndrome From Stable Angina, ARYA Atherosclerosis (2020)
18. Blood Group Types and Clinical, Procedural, and Adverse Outcomes in St-Elevated Myocardial Infarction Patients: A 3-Year Cohort in Iran, Journal of Research in Medical Sciences (2023)
19. Preconditioning by Isoflurane As a Volatile Anesthetic in Elective Coronary Artery Bypass Surgery, ARYA Atherosclerosis (2013)
20. Intakes of Vegetables and Fruits Are Negatively Correlated With Risk of Stroke in Iran, International Journal of Preventive Medicine (2013)
21. High Sensitive C-Reactive Protein Serum Levels in Patients With Acute Coronary Syndrome, Journal of Isfahan Medical School (2012)
22. Effect of Lycopene Supplementation on Some Cardiovascular Risk Factors and Markers of Endothelial Function in Iranian Patients With Ischemic Heart Failure: A Randomized Clinical Trial, Cardiology Research and Practice (2022)
23. L-Carnitine and Potential Protective Effects Against Ischemia-Reperfusion Injury in Noncardiac Organs: From Experimental Data to Potential Clinical Applications, Journal of Dietary Supplements (2018)
24. Clinical, Laboratory, and Procedural Predictors of Slow Flow/No Reflow Phenomenon After Emergency Percutaneous Coronary Interventions in St-Elevated Myocardial Infarction, Egyptian Heart Journal (2024)
25. Can C-Reactive Protein and Fibrinogen Predict Major Adverse Cardiac Events in Cardiovascular and Cerebrovascular Patients?, Iranian Heart Journal (2015)
26. Lycopene Supplementation and Blood Pressure: Systematic Review and Meta-Analyses of Randomized Trials, Journal of Herbal Medicine (2022)
27. The Validity of High-Sensitive Cardiac Troponin I Serum Level in Comparison to Myocardial Perfusion Imaging in Patient With Cardiac Angina, Journal of Isfahan Medical School (2020)